All current DZIF news can be found here.

© Universität Tübingen / Paul Mehnert

Tübingen study raises hope for effective malaria vaccine

At the University Hospital of Tübingen, a clinical trial led by Prof. Dr. Peter Kremsner, Director of the Institute of Tropical Medicine, Travel Medicine and Human Parasitology and Dr. Rolf Fendel

Kamele in Dubai

MERS coronavirus: Vaccine development is going into the next round

In addition to the SARS coronavirus-2 that is currently prevalent worldwide, scientists continue to keep an eye on the related MERS coronavirus, as it, too, could potentially become a supra-regional

Hans-Peter Grobbel
© FZ Borstel

Tailor-made therapy of multi-resistant tuberculosis

The successful treatment of multidrug-resistant tuberculosis requires clarification in advance as to which antibiotics the pathogens are resistant to. Classic testing in the laboratory is very time

Struktur SUD Paip1
© J. Lei et al., 2021, EMBO Journal

How SARS-coronaviruses reprogram the human cell to their own benefit

DZIF scientists Prof. Rolf Hilgenfeld of the University of Lübeck and Dr. Albrecht von Brunn of the Ludwig-Maximilians University of Munich  discovered how SARS viruses enhance the production of viral

© Sonja Taut / MPI of Biochemistry

A multidimensional view of the coronavirus

What exactly happens when the corona virus SARS-CoV-2 infects a cell? In an article published in Nature, a team from the Technical University of Munich (TUM) and the Max Planck Institute of

Coronaviren als Bedrohung
© Tumisu auf Pixabay

Will COVID-19 vaccines need to be adapted regularly?

Influenza vaccines need to be evaluated every year to ensure they remain effective against new influenza viruses. Will the same apply to COVID-19 vaccines? In order to gauge whether and to what extent

Christoph Lange
© FZ Borstel

The clock is ticking! Three people dying of tuberculosis every minute

The clock is ticking: The motto of this year's World Tuberculosis Day makes clear that tuberculosis still remains one of the world's deadliest infections. In particular, people in poorer countries are

© Rasche

Hepatitis B: What people can learn from donkeys

The discovery of a previously unknown hepatitis B virus in donkeys and zebras opens up new opportunities for understanding the course of the disease. A global research consortium was able to show that

© fernando zhiminaicela auf Pixabay

New consortium coordinates research on COVID-19 vaccines in Europe

The need for vaccine studies continues to be high, as many questions remain unanswered about the safety, efficacy and possibly necessary adaptation of vaccines to emerging virus variants. In order to

Christoph Lange untersucht einen Patienten

Tuberculosis: New biomarker indicates individual treatment duration

The treatment of tuberculosis (TB) is long, demanding, and expensive. In particular, the ever increasing emergence of resistant tuberculosis bacteria requires a lot of patience: In these cases, the